LYNX DX, INC.
Northville, MI · Founded 2015 · CIK 0001799277 · Medtech · Private
Urine biomarker assay combining TMPRSS2:ERG fusion and PCA3 gene detection with PSA to generate MPS risk score for prostate cancer diagnosis
lynxdx.com →- Grants
- $3.0M
- 2 awards
- Sector median: 1
- Raised
- $925K
- 1 Form D · Jan 2020
- 80 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $925,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Urine Diagnostic Tool for the Detection of High-grade Prostate Cancer | $1,999,642 | |
| Federal grant | Department of Health and Human Services · Phase II · Urine Diagnostic Tool for the Detection of High-grade Prostate Cancer | $995,327 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1340 | OncoVerity, Inc. | — | $18M |
| 1341 | Persperion Diagnostics Inc. | — | $4.4M |
| 1342 | Eyedaptic, Inc. | — | $928K |
| 1343 | LYNX DX, INC. | — | $925K |
| 1344 | Aethon Medical | — | — |
| 1345 | Simulated Inanimate Models LLC | — | $900K |
| 1346 | NOVOPYXIS INC. | — | $856K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Arul ChinnaiyanDirector · Executive Officer
- Matt MartinExecutive Officer
- Yashar NikafsExecutive Officer
Patents
- Methods For Rna Extraction And Detection From A Urine Sampleapplication
- Methods For Rna Extraction And Detection From A Urine Sampleapplication
- Methods For Rna Extraction And Detection From A Urine Sampleapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.